AI Index / Schrödinger, Inc.
Schrödinger, Inc. (SDGR)
Schrödinger, a company specializing in computational platforms for molecular discovery, integrates advanced machine learning into its software to enhance drug discovery processes. This includes initiatives like predictive toxicology, supported by a $10 million grant from the Gates Foundation, aiming to anticipate toxicological risks early in drug development.
Loading...
We are maintaining our full year software revenue growth guidance, reflecting the productive conversations we're having with our software customers around renewals and scale-ups in the second half of the year.
- Ramy Farid
Similar Companies in the Swift AI Index
Quotes from schrdinger Executives About Artificial Intelligence and Generative AI
We are continuing to make significant improvements to the performance and usability of our software platform and continue to add streamlined workflows to enhance the user experience and make our software more accessible to scientists without a computational chemistry background.
- Ramy Farid
We are also advancing our predictive toxicology initiative in support of the FDA's efforts to modernize drug discovery through its new alternative methods program to reduce reliance on animal models, including through the development and deployment of predictive computational models.
- Ramy Farid
All of our collaborators have access to the technology through the collaboration. So we've been using it internally. And as we've said before, we can share with you that it's having an impact. It works.
- Ramy Farid
There's a clear demand for advanced technology, predictive technologies. And so far, we're really pleased with the discussions.
- Ramy Farid
The intention, of course, is to engage with the FDA at the appropriate time when the technology is in the state where we feel that's appropriate.
- Ramy Farid